杜皮鲁玛
耐久性
医学
免疫学
计算机科学
哮喘
数据库
作者
Claus Bachert,Asif Khan,Wytske J. Fokkens,Claire Hopkins,Philippe Gevaert,Joseph K. Han,Peter W. Hellings,Stella E. Lee,Jérôme Msihid,Scott D. Nash,Harry Sacks,Juby A. Jacob‐Nara,Yamo Deniz,Paul J. Rowe
标识
DOI:10.1016/j.jaci.2024.07.026
摘要
Responder analyses of SINUS phase 3 study data have shown clinically meaningful improvements across multiple chronic rhinosinusitis with nasal polyps (CRSwNP) outcomes with dupilumab.
科研通智能强力驱动
Strongly Powered by AbleSci AI